Canada Funds Prostate Cancer Chemogenomics | GenomeWeb

NEW YORK (GenomeWeb News) – Scientists at the Vancouver Prostate Centre will use C$324,000 ($318,000) in new funding to conduct chemogenomic screening of millions of compounds in search of potential new drugs to treat prostate cancer, Genome British Columbia said Monday.

Genome BC awarded the researchers C$162,000 from its Strategic Opportunities Fund, and the remaining support came from the Canadian Institutes of Health Research and from the Vancouver Prostate Centre.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.